Inhibrx Biosciences (INBX) Proxy filing summary

Executive summary

• The annual meeting is scheduled for June 3, 2026, and will be held virtually, allowing shareholders to vote and ask questions online.

• Shareholders will vote on electing two Class II directors and ratifying the appointment of BDO USA, P.C. as the independent auditor for 2026.

• Only shareholders of record as of April 7, 2026, are eligible to vote, with 14,607,286 shares outstanding.

• The company completed a major restructuring in 2024, spinning off from its former parent and transferring key assets.

Voting matters and shareholder proposals

• Proposal 1: Elect Douglas G. Forsyth and Kimberly Manhard as Class II directors for a term ending in 2029.

• Proposal 2: Ratify BDO USA, P.C. as the independent registered public accounting firm for 2026.

• Board recommends voting FOR both proposals.

• Shareholders may submit proposals for the 2027 meeting between February 3 and March 5, 2027.

Board of directors and corporate governance

• The board consists of five members divided into three classes, with annual elections for each class.

• All directors except the CEO are independent under Nasdaq rules.

• The board has Audit, Compensation, and Nominating and Corporate Governance Committees, all composed of independent directors.

• The company has adopted a Corporate Code of Conduct, Whistleblower Policy, Insider Trading Policy, and Clawback Policy.

• Directors are encouraged to attend annual meetings, and all attended in 2025.